Systemic Mastocytosis Latest Advances

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: September 30, 2025

Systemic Mastocytosis.

Journal: The New England journal of medicine

Published: September 22, 2025

Anesthetic Considerations for Cesarean Section in a Woman With Systemic Mastocytosis.

Journal: Cureus

Published: September 21, 2025

Cardiovascular manifestations in mast cell activation disease: key insights for cardiologists and angiologists.

Journal: Frontiers in cardiovascular medicine

Published: September 14, 2025

Aggressive Systemic Mastocytosis Presenting as Pyrexia of Unknown Origin and Sclerotic Bone Lesions: An Uncommon Presentation of a Rare Haematological Disorder.

Journal: Cureus

Published: September 12, 2025

Systemic Mastocytosis Latest Advances

Find the Latest Research About Systemic Mastocytosis

Refractory cutaneous symptoms in systemic mastocytosis.

Refractory cutaneous symptoms in systemic mastocytosis.

Systemic mastocytosis for the practicing clinician: overview, diagnostic features, prognostication and antiproliferative treatment in the era of targeted therapy.

Systemic mastocytosis for the practicing clinician: overview, diagnostic features, prognostication and antiproliferative treatment in the era of targeted therapy.

Investigating instruments for evaluation of gastrointestinal burdens in patients with systemic mastocytosis: an exploratory multimethod study.

Investigating instruments for evaluation of gastrointestinal burdens in patients with systemic mastocytosis: an exploratory multimethod study.

Lampson B, Zakharyan A, Shimony SO, Shi H, Deangelo D. Analysis of avapritinib clinical trial data generates a highly accurate predictive model for advanced systemic mastocytosis versus indolent systemic mastocytosis based on peripheral blood testing. Blood. 2024;144(suppl 1):107.

Lampson B, Zakharyan A, Shimony SO, Shi H, Deangelo D. Analysis of avapritinib clinical trial data generates a highly accurate predictive model for advanced systemic mastocytosis versus indolent systemic mastocytosis based on peripheral blood testing. Blood. 2024;144(suppl 1):107.

Avapritinib in the treatment of systemic mastocytosis with associated acute myeloid leukemia after poor graft function following allogeneic hematopoietic stem cell transplantation: a case study and review of the literature.

Avapritinib in the treatment of systemic mastocytosis with associated acute myeloid leukemia after poor graft function following allogeneic hematopoietic stem cell transplantation: a case study and review of the literature.

Management of mastocytosis and mast cell activation in children.

Management of mastocytosis and mast cell activation in children.

Case Report: A rare case of synchronous ovarian mixed germ cell tumor and mast cell leukemia in a pediatric patient.

Case Report: A rare case of synchronous ovarian mixed germ cell tumor and mast cell leukemia in a pediatric patient.

Biconcave vertebral fractures as a possible distinctive feature of indolent systemic mastocytosis compared with primary osteoporosis.

Biconcave vertebral fractures as a possible distinctive feature of indolent systemic mastocytosis compared with primary osteoporosis.

Systemic Mastocytosis.

Systemic Mastocytosis.

Anesthetic Considerations for Cesarean Section in a Woman With Systemic Mastocytosis.

Anesthetic Considerations for Cesarean Section in a Woman With Systemic Mastocytosis.

Cardiovascular manifestations in mast cell activation disease: key insights for cardiologists and angiologists.

Cardiovascular manifestations in mast cell activation disease: key insights for cardiologists and angiologists.

Aggressive Systemic Mastocytosis Presenting as Pyrexia of Unknown Origin and Sclerotic Bone Lesions: An Uncommon Presentation of a Rare Haematological Disorder.

Aggressive Systemic Mastocytosis Presenting as Pyrexia of Unknown Origin and Sclerotic Bone Lesions: An Uncommon Presentation of a Rare Haematological Disorder.